Glycolytic activation in cervical cancer is partially achieved by the HPV oncoprotein E6, which downregulates miR-34a, resulting in the upregulation of the miR-34a target and glycolytic enzyme lactate dehydrogenase A (LDHA) [71]. The gene discussed is LDHA; the disease is cervical carcinoma.